WO2024129709A1 - Stent - Google Patents

Stent Download PDF

Info

Publication number
WO2024129709A1
WO2024129709A1 PCT/US2023/083596 US2023083596W WO2024129709A1 WO 2024129709 A1 WO2024129709 A1 WO 2024129709A1 US 2023083596 W US2023083596 W US 2023083596W WO 2024129709 A1 WO2024129709 A1 WO 2024129709A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
artery
connection mechanisms
side walls
shaped component
Prior art date
Application number
PCT/US2023/083596
Other languages
French (fr)
Inventor
Samuel BREHM
Original Assignee
Status Flow Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Status Flow Llc filed Critical Status Flow Llc
Publication of WO2024129709A1 publication Critical patent/WO2024129709A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/844—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents folded prior to deployment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028—Shapes in the form of latin or greek characters
    • A61F2230/0054—V-shaped
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063—Three-dimensional shapes
    • A61F2230/0091—Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001—Designing or manufacturing processes

Definitions

  • the present invention relates generally to a stent. More specifically, the invention relates to a stent for placement in an artery.
  • spiral laminar flow The predominant flow pattern inside arteries is spiral laminar flow.
  • the presence of spiral laminar flow may cause reduced low-density lipoprotein transport, improved oxygen transport, flow stabilization at branches of the artery, and improved flow through stenosis.
  • Loss of spiral laminar flow can lead to undesirable consequences.
  • fluid e.g., blood
  • non-spiral laminar flow may flow in the middle of an artery, and the blood may reach the intima at the tip of the bifurcation, which may force the blood to split into separate branches of the artery. This may cause weakening and/or ballooning of the arterial wall at the bifurcation, which may cause an aneurysm.
  • saccular (“berry”) aneurysms may occur at bifurcations of the arteries.
  • treatment for cerebral aneurysms has, in recent years, shifted from open surgery to endovascular treatment, certain cerebral aneurysms may not be treated endovascularly.
  • endovascular treatment is not used for large aneurysms that occur at a wide-neck bifurcation of the middle cerebral artery, due to lack of adequate treatment and tools.
  • the present invention overcomes many of the shortcomings and limitations of the prior art devices discussed above.
  • the invention described herein includes several embodiments of a stent.
  • endovascular treatments are not currently available for all types of aneurysms, including cerebral bifurcation aneurysms. Encouraging or generating spiral laminar flow in arteries may improve blood flow and aid in lessening the undesirable effects of standard blood flow in arteries (e.g., weakening and/or ballooning of an artery).
  • the stent described and provided herein may be spiral -shaped, such that when placed in an artery, the stent may be configured to encourage or generate spiral laminar flow in an artery. This may aid in preventing blood from being physically forced to split into separate branches after reaching and pressing against the tip of the bifurcation. This may assist in reducing wall shear of the artery, which may, in turn, reduce the effects of wall shear (e.g., aneurysms).
  • wall shear e.g., aneurysms
  • FIG. 1 is a top view of a stent within a stent insertion device placed within an artery constructed according to the teachings of the present application;
  • FIG. 2 is a perspective view of the stent within the stent insertion device of Fig. 1;
  • FIG. 3 is a perspective view of the stent of Fig. 1 in a compressed state
  • Fig. 4 is a perspective view of the stent of Fig. 1 in an expanded state within the artery;
  • Fig. 5 is a perspective view of the stent of Fig. 1 in the expanded state.
  • a stent 1 may be placed within a stent insertion device 5.
  • the stent insertion device 5 may be configured to place the stent 1 within an artery 10.
  • the stent 1 may be used when an aneurysm 15 develops along or within the artery 10.
  • the stent 1 may be received within an interior portion 20 of the stent insertion device 5.
  • the stent 1 When received within the interior portion 20 of the stent insertion device 5, the stent 1 may be in a compressed state, as illustrated in Fig. 3.
  • the stent insertion device 5 may cause the stent 1 to remain in a compressed state.
  • the compressed state corresponds to the size of the stent insertion device 5, such that the stent 1 expands only to the maximum extent permitted by the size of the stent insertion device 5.
  • the stent 1 When released or separated from the stent insertion device 5, as illustrated in Fig. 4, the stent 1 may be in an expanded state. According to one embodiment, when the stent 1 is positioned in the correct place within the artery 10, a surgeon may release the stent 1 from the stent insertion device 5. In alternative embodiments, the stent 1 may be automatically released from the stent insertion device 5. When released, the stent 1 may expand within the artery 10. The stent 1 may be placed within the artery 10 to encourage or generate spiral laminar flow. The stent 1 may be spiral shaped. Such shape may encourage spiral laminar flow within the artery 10.
  • the stent 1 may be configured to cause the blood to spin in a spiral manner upstream of a bifurcation 25 and/or the aneurysm 15.
  • the spiral shape of the stent 1 may cause blood to be pressed against walls 30 of the artery 10 due to centrifugal force. This may be valuable to treatment of the aneurysm 15, because the stent 1 may aid in reducing the impact of blood at the aneurysm 15.
  • Such placement of the stent 1 may encourage the blood to be directed to branches 35a, 35b at the bifurcation 25 without affecting the aneurysm 15.
  • the stent 1 may be used to treat a wall aneurysm. Spinning the blood via the spiral shape of the stent 1 may assist in boundary layer separate inside of the artery with a wall aneurysm, which may assist in resolving the wall aneurysm.
  • the arrows 40 illustrate how blood may flow through the artery 10 and into the branches 35a, 35b.
  • the stent 1 When manufactured, the stent 1 may be a flat component, as illustrated in Fig. 5, and the stent 1 may then be twisted to be formed into a spiral shape. The stent 1 may be designed to be compressed into a spiral shape in the short axis.
  • the stent 1 may include side walls 45. According to one embodiment, and as illustrated, the stent 1 includes two side walls 45a, 45b.
  • the side walls 45a, 45b may connect.
  • the side walls 45a, 45b attach or are integrally formed with one another at the first end 50.
  • the side walls 45a, 45b may form a first connection point 55 at the first end 50.
  • the first connection point 55 may be formed such that the side walls 45a, 45b come to a singular point at the first end 50.
  • the side walls 45a, 45b may be connected via one or more connection mechanisms 65.
  • the one or more connection mechanisms 65 may be wishbone shaped.
  • the one or more connection mechanisms 65 may be any other suitable shape or size.
  • connection mechanisms 65 may be spaced apart such that blood may flow through and around the stent 1.
  • the side walls 45a, 45b may be connected via a single connection mechanism 65 which extends the lengths of the side walls 45a, 45b. In such a configuration, the blood may flow around the stent 1 but may not necessarily flow through the stent 1.
  • the side walls 45a, 45b may connect at a second connection point 75.
  • the side walls 45a, 45b attach to or are integrally formed with one another at the second end 70.
  • the second connection point 75 may be formed via a connection mechanism 65 attached to end points 80a, 80b of each of the side walls 45a, 45b, respectively.
  • the connection mechanism 65 may connect the side walls 45a, 45b to one another.
  • the one or more connection mechanisms 65 described herein may be attached to or integrally formed with the side walls 45a, 45b.
  • the first end 50 corresponds to an end of the stent 1 positioned further from the aneurysm 15
  • the second end 70 corresponds to an end of the stent 1 positioned closer to the aneurysm.
  • the side walls 45a, 45b may or may not be parallel.
  • the side walls 45a, 45b may taper toward one another from the first end 50 to the second end 70.
  • the one or more connection mechanisms 65 may be different lengths depending on the positioning relative to the first end
  • the stent 1 may be made of any suitable material, including, but not limited to, thin nitinol, titanium, stainless steel, or wire.
  • the metal frame of the stent 1 may be covered in a covering material, such as Dacron®.
  • the stent 1 may include a removal component, which may be used to remove the stent 1 from the artery 10.
  • the removal component may be attached at the first end 50 or the second end 70 of the stent. According to one embodiment, the removal component is threaded into the first connection point 55 of the first end 50.
  • the stent 1 may be formed or configured in any suitable manner. Further, the attachments described herein may be achieved using any suitable manner now known or developed in the art.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

The stent described and provided herein may be received within a stent insertion device in order to be placed within an artery. When removed from the stent insertion device, the stent may expand into an expanded state and be positioned within the artery. The stent may be spiral shaped, such that, when placed in the artery, the stent may be configured to encourage or generate spiral laminar flow in the artery. The spiral shape of the stent may cause the blood to split into separate branches without pressing against the tip of the bifurcation and causing damage or further issues to an artery or already-developed aneurysm.

Description

STENT
Cross-Reference to Related Applications
[0001] The present application claims priority to U.S. Provisional Patent Application No. 63/386,982, filed December 12, 2022, the entire contents of which are hereby incorporated by reference.
Field of Invention
[0002] The present invention relates generally to a stent. More specifically, the invention relates to a stent for placement in an artery.
Background of Invention
[0003] The predominant flow pattern inside arteries is spiral laminar flow. The presence of spiral laminar flow may cause reduced low-density lipoprotein transport, improved oxygen transport, flow stabilization at branches of the artery, and improved flow through stenosis. Loss of spiral laminar flow can lead to undesirable consequences. For example, fluid (e.g., blood) flowing via non-spiral laminar flow may flow in the middle of an artery, and the blood may reach the intima at the tip of the bifurcation, which may force the blood to split into separate branches of the artery. This may cause weakening and/or ballooning of the arterial wall at the bifurcation, which may cause an aneurysm.
[0004] In cerebral arteries, saccular (“berry”) aneurysms may occur at bifurcations of the arteries. Although treatment for cerebral aneurysms has, in recent years, shifted from open surgery to endovascular treatment, certain cerebral aneurysms may not be treated endovascularly. For example, endovascular treatment is not used for large aneurysms that occur at a wide-neck bifurcation of the middle cerebral artery, due to lack of adequate treatment and tools. As such, a need exists for an endovascular treatment that may be used for cerebral aneurysms, despite their locations or size.
Summary of Invention
[0005] The present invention overcomes many of the shortcomings and limitations of the prior art devices discussed above. The invention described herein includes several embodiments of a stent.
[0006] As stated above, endovascular treatments are not currently available for all types of aneurysms, including cerebral bifurcation aneurysms. Encouraging or generating spiral laminar flow in arteries may improve blood flow and aid in lessening the undesirable effects of standard blood flow in arteries (e.g., weakening and/or ballooning of an artery).
[0007] The stent described and provided herein may be spiral -shaped, such that when placed in an artery, the stent may be configured to encourage or generate spiral laminar flow in an artery. This may aid in preventing blood from being physically forced to split into separate branches after reaching and pressing against the tip of the bifurcation. This may assist in reducing wall shear of the artery, which may, in turn, reduce the effects of wall shear (e.g., aneurysms).
Brief Description of Drawings
[0008] Fig. 1 is a top view of a stent within a stent insertion device placed within an artery constructed according to the teachings of the present application;
[0009] Fig. 2 is a perspective view of the stent within the stent insertion device of Fig. 1;
[0010] Fig. 3 is a perspective view of the stent of Fig. 1 in a compressed state; [0011] Fig. 4 is a perspective view of the stent of Fig. 1 in an expanded state within the artery; and
[0012] Fig. 5 is a perspective view of the stent of Fig. 1 in the expanded state.
[0013] While the disclosure is susceptible to various modifications and alternative forms, a specific embodiment thereof is shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that the drawings and detailed description presented herein are not intended to limit the disclosure to the particular embodiment disclosed, but to the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.
Detailed Description
[0014] The invention will now be described with reference to the drawing figures, in which like reference numerals refer to like parts throughout. For purposes of clarity in illustrating the characteristics of the present invention, proportional relationships of the elements have not necessarily been maintained in the drawing figures.
[0015] Turning first to Fig. 1, a stent 1 may be placed within a stent insertion device 5. The stent insertion device 5 may be configured to place the stent 1 within an artery 10. According to one embodiment, the stent 1 may be used when an aneurysm 15 develops along or within the artery 10. As illustrated in Fig. 2, the stent 1 may be received within an interior portion 20 of the stent insertion device 5. When received within the interior portion 20 of the stent insertion device 5, the stent 1 may be in a compressed state, as illustrated in Fig. 3. The stent insertion device 5 may cause the stent 1 to remain in a compressed state. According to one embodiment, the compressed state corresponds to the size of the stent insertion device 5, such that the stent 1 expands only to the maximum extent permitted by the size of the stent insertion device 5.
[0016] When released or separated from the stent insertion device 5, as illustrated in Fig. 4, the stent 1 may be in an expanded state. According to one embodiment, when the stent 1 is positioned in the correct place within the artery 10, a surgeon may release the stent 1 from the stent insertion device 5. In alternative embodiments, the stent 1 may be automatically released from the stent insertion device 5. When released, the stent 1 may expand within the artery 10. The stent 1 may be placed within the artery 10 to encourage or generate spiral laminar flow. The stent 1 may be spiral shaped. Such shape may encourage spiral laminar flow within the artery 10.
[0017] When blood flows through the artery 10 with a stent 1 placed, the blood may be encouraged to flow in a spiral manner. The stent 1 may be configured to cause the blood to spin in a spiral manner upstream of a bifurcation 25 and/or the aneurysm 15. The spiral shape of the stent 1 may cause blood to be pressed against walls 30 of the artery 10 due to centrifugal force. This may be valuable to treatment of the aneurysm 15, because the stent 1 may aid in reducing the impact of blood at the aneurysm 15. Such placement of the stent 1 may encourage the blood to be directed to branches 35a, 35b at the bifurcation 25 without affecting the aneurysm 15. Further, the stent 1 may be used to treat a wall aneurysm. Spinning the blood via the spiral shape of the stent 1 may assist in boundary layer separate inside of the artery with a wall aneurysm, which may assist in resolving the wall aneurysm. The arrows 40 illustrate how blood may flow through the artery 10 and into the branches 35a, 35b.
[0018] When manufactured, the stent 1 may be a flat component, as illustrated in Fig. 5, and the stent 1 may then be twisted to be formed into a spiral shape. The stent 1 may be designed to be compressed into a spiral shape in the short axis. The stent 1 may include side walls 45. According to one embodiment, and as illustrated, the stent 1 includes two side walls 45a, 45b.
[0019] At a first end 45, the side walls 45a, 45b may connect. According to various embodiments, the side walls 45a, 45b attach or are integrally formed with one another at the first end 50. The side walls 45a, 45b may form a first connection point 55 at the first end 50. The first connection point 55 may be formed such that the side walls 45a, 45b come to a singular point at the first end 50. Through a middle portion 60 of the stent 1, the side walls 45a, 45b may be connected via one or more connection mechanisms 65. According to various embodiments, the one or more connection mechanisms 65 may be wishbone shaped. The one or more connection mechanisms 65 may be any other suitable shape or size. The one or more connection mechanisms 65 may be spaced apart such that blood may flow through and around the stent 1. According to one embodiment, the side walls 45a, 45b may be connected via a single connection mechanism 65 which extends the lengths of the side walls 45a, 45b. In such a configuration, the blood may flow around the stent 1 but may not necessarily flow through the stent 1.
[0020] At a second end 70 of the stent 1, the side walls 45a, 45b may connect at a second connection point 75. According to various embodiments, the side walls 45a, 45b attach to or are integrally formed with one another at the second end 70. According to one embodiment, the second connection point 75 may be formed via a connection mechanism 65 attached to end points 80a, 80b of each of the side walls 45a, 45b, respectively. In such a configuration, the connection mechanism 65 may connect the side walls 45a, 45b to one another. The one or more connection mechanisms 65 described herein may be attached to or integrally formed with the side walls 45a, 45b. According to one embodiment, the first end 50 corresponds to an end of the stent 1 positioned further from the aneurysm 15, and the second end 70 corresponds to an end of the stent 1 positioned closer to the aneurysm. As illustrated, the side walls 45a, 45b may or may not be parallel. The side walls 45a, 45b may taper toward one another from the first end 50 to the second end 70. As such, the one or more connection mechanisms 65 may be different lengths depending on the positioning relative to the first end
50 and the second end 70.
[0021] The stent 1 may be made of any suitable material, including, but not limited to, thin nitinol, titanium, stainless steel, or wire. The metal frame of the stent 1 may be covered in a covering material, such as Dacron®. The stent 1 may include a removal component, which may be used to remove the stent 1 from the artery 10. The removal component may be attached at the first end 50 or the second end 70 of the stent. According to one embodiment, the removal component is threaded into the first connection point 55 of the first end 50. Although described above as having a particular shape or configuration, the stent 1 may be formed or configured in any suitable manner. Further, the attachments described herein may be achieved using any suitable manner now known or developed in the art.
[0022] As is evident from the foregoing description, certain aspects of the present invention are not limited by the particular details of the examples illustrated herein, and it is therefore contemplated that other modifications, applications, variations, or equivalents thereof, will occur to those skilled in the art. Many such changes, modifications, variations, and other uses and applications of the present constructions will, however, become apparent to those skilled in the art after considering the specification and the accompanying drawings. In addition, unless mention was made above to the contrary, it should be noted that all of the accompanying drawings are not to scale. All such changes, modifications, variations, and other uses and applications which do not depart from the spirit and scope of the present inventions are deemed to be covered by the inventions which are limited only by the claims which follow.

Claims

Claims
1. A stent comprising: a spiral shaped component comprising: a plurality of side walls; and one or more connection mechanisms configured to connect the plurality of side walls; wherein the spiral shaped component is configured to be placed in an artery; and wherein the spiral shaped component is configured to generate spiral laminar flow of blood flowing in the artery.
2. The stent of claim 1, wherein each of the one or more connection mechanisms are spaced apart from the other one or more connection mechanisms to form a plurality of spaces.
3. The stent of claim 2, wherein blood flows through the plurality of spaces between the one or more connection mechanisms.
4. The stent of claim 1, wherein the spiral shaped component is made of at least one of thin nitinol, titanium, stainless steel, or wire.
5. The stent of claim 1, wherein the spiral shaped component comprises a coating material.
6. The stent of claim 1, wherein when the stent is in a first configuration, the stent is substantially flat, and wherein when the stent is in a second configuration, the stent is spiral shaped.
7. The stent of claim 1, wherein the spiral shaped component is configured to be placed in the artery ahead of a bifurcation, and wherein the spiral shaped component is configured to transport blood away from a tip of the bifurcation.
8. The stent of claim 1, wherein when received within a stent insertion device, the stent is in a compressed state, and wherein when removed from the stent insertion device and placed within the artery, the stent is in an expanded state.
9. A method for manufacturing a stent comprising: connecting a plurality of side walls via one or more connection mechanisms; developing a substantially flat component from the connected plurality of side walls and one or more connection mechanisms; twisting the substantially flat component into a spiral shape; and placing the stent in a stent insertion device for subsequent delivery into an artery.
10. The method of claim 9, wherein each of the one or more connection mechanisms are spaced apart from the other one or more connection mechanisms to form a plurality of spaces.
11. The method of claim 10, wherein blood flows through the plurality of spaces between the one or more connection mechanisms.
12. The method of claim 9, wherein the plurality of side walls and the one or more connection mechanisms are made of at least one of thin nitinol, titanium, stainless steel, or wire.
13. The method of claim 9, wherein each of the plurality of side walls and the one or more connection mechanisms comprise a coating material.
14. The method of claim 9, wherein when received within the stent insertion device, the stent is in a compressed state, and wherein when removed from the stent insertion device and placed within the artery, the stent is in an expanded state.
15. The method of claim 9, wherein the stent is configured to be placed in the artery ahead of a bifurcation.
16. The method of claim 15, wherein the stent is configured to generate spiral laminar flow of blood flowing in the artery.
17. A stent comprising: a spiral shaped component comprising: a plurality of side walls; and one or more connection mechanisms configured to connect the plurality of side walls; wherein the spiral shaped component is configured to be placed in an artery.
18. The stent of claim 17, wherein the spiral shaped component is configured to be placed in the artery ahead of a bifurcation.
19. The stent of claim 17, wherein the spiral shaped component is configured to generate spiral laminar flow of blood flowing in the artery.
20. The stent of claim 18, wherein the spiral shaped component is configured to transport blood away from a tip of the bifurcation.
5
PCT/US2023/083596 2022-12-12 2023-12-12 Stent WO2024129709A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263386982P 2022-12-12 2022-12-12
US63/386,982 2022-12-12

Publications (1)

Publication Number Publication Date
WO2024129709A1 true WO2024129709A1 (en) 2024-06-20

Family

ID=91486279

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/083596 WO2024129709A1 (en) 2022-12-12 2023-12-12 Stent

Country Status (1)

Country Link
WO (1) WO2024129709A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19531659C2 (en) * 1995-08-29 1998-07-02 Ernst Peter Prof Dr M Strecker Stent
US20030114920A1 (en) * 1999-12-21 2003-06-19 Caro Colin Gerald Vascular stents
US20060079955A1 (en) * 2004-10-07 2006-04-13 Scimed Life Systems, Inc. Non-shortening helical stent
US20200289149A1 (en) * 2016-01-15 2020-09-17 Tva Medical, Inc. Systems and methods for increasing blood flow

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19531659C2 (en) * 1995-08-29 1998-07-02 Ernst Peter Prof Dr M Strecker Stent
US20030114920A1 (en) * 1999-12-21 2003-06-19 Caro Colin Gerald Vascular stents
US20060079955A1 (en) * 2004-10-07 2006-04-13 Scimed Life Systems, Inc. Non-shortening helical stent
US20200289149A1 (en) * 2016-01-15 2020-09-17 Tva Medical, Inc. Systems and methods for increasing blood flow

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KOO YOUNGMI, TIASHA TARANNUM, SHANOV VESSELIN N., YUN YEOHEUNG: "Expandable Mg-based Helical Stent Assessment using Static, Dynamic, and Porcine Ex Vivo Models", SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, US, vol. 7, no. 1, US , XP093186305, ISSN: 2045-2322, DOI: 10.1038/s41598-017-01214-4 *

Similar Documents

Publication Publication Date Title
US20200038208A1 (en) Method and apparatus for stenting
US11166731B2 (en) Systems and methods for treating aneurysms
EP3669800A1 (en) Intrasaccular flow diverter for treating cerebral aneurysms
JP2005522265A (en) Intravascular blood flow adjusting device and reinforcing device having a connecting segment
JP5912317B2 (en) False lumen occluder
US20040193141A1 (en) Intravascular flow modifier and reinforcement device and deployment system for same
JP2013081868A (en) Flexible vascular occluding device
KR20210157348A (en) Catheter mouth designs
US9095420B2 (en) Endovascular stent
KR20210158349A (en) Clot retrieval device with flexible collapsible frame
US9782280B2 (en) Optimal ratio of polar and bending moment of inertia for stent strut design
JP2004283591A (en) Anvil bridge stent design
EP2777639A1 (en) Improved radiopaque marker for vascular devices
US20140094901A1 (en) Radiopaque marker for vascular devices
WO2024129709A1 (en) Stent
US20150238334A1 (en) Implant for Treating Aneurysms
WO2011149598A1 (en) Stent having optimized expansion ratio
US20150039075A1 (en) Variable stiffness stent
US11583423B2 (en) Expandable tube for deployment within a blood vessel
CN111315323A (en) Implanted damping device for changing blood flow characteristics
WO2001043810A1 (en) Stent
EP2327379A1 (en) Stent
US20110251672A1 (en) Aspect ratio for stent strut design

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23904440

Country of ref document: EP

Kind code of ref document: A1